tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

HIMS Stock Latest News

Sell Rating for Hims & Hers Health Due to Slowing Sales Growth and Regulatory Risks
RatingsSell Rating for Hims & Hers Health Due to Slowing Sales Growth and Regulatory Risks
5d ago
HIMS
Hims & Hers price target raised to $25 from $21 at Jefferies
PremiumThe Fly
Hims & Hers price target raised to $25 from $21 at Jefferies
10d ago
HIMS
Hims & Hers price target lowered to $33 from $39 at Truist
PremiumThe Fly
Hims & Hers price target lowered to $33 from $39 at Truist
11d ago
HIMS
‘Hold the Phone,’ Says Morgan Stanley on Hims & Hers Health Stock (HIMS)
PremiumMarket News
‘Hold the Phone,’ Says Morgan Stanley on Hims & Hers Health Stock (HIMS)
18d ago
LLY
NVO
‘Too Hot to Handle,’ Analyst Warning on Hims & Hers Health Stock (HIMS)
PremiumMarket News
‘Too Hot to Handle,’ Analyst Warning on Hims & Hers Health Stock (HIMS)
19d ago
HIMS
NYSE
Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty
PremiumMarket NewsAnalysts Stay Cautious on HIMS Stock amid Core Business Uncertainty
19d ago
HIMS
Hims & Hers falls -5.0%
Premium
The Fly
Hims & Hers falls -5.0%
19d ago
HIMS
Hims & Hers falls -6.1%
Premium
The Fly
Hims & Hers falls -6.1%
19d ago
HIMS
Morgan Stanley says Hims branded tirzepatide margins likely well below compounds
PremiumThe Fly
Morgan Stanley says Hims branded tirzepatide margins likely well below compounds
19d ago
LLY
HIMS
Sell Rating for Hims & Hers Health Due to High Pricing and Limited Market Penetration of New Offerings
PremiumRatings
Sell Rating for Hims & Hers Health Due to High Pricing and Limited Market Penetration of New Offerings
19d ago
HIMS
Cautious Outlook on Hims & Hers Health Amid Expansion and Margin Concerns
PremiumRatings
Cautious Outlook on Hims & Hers Health Amid Expansion and Margin Concerns
19d ago
HIMS
Citi sees high price of Tirzepatide on Hims & Hers being ‘prohibitive’
PremiumThe Fly
Citi sees high price of Tirzepatide on Hims & Hers being ‘prohibitive’
19d ago
LLY
HIMS
Sell Rating for Hims & Hers Health Amid Low Margin Concerns and Competitive Pricing
PremiumRatingsSell Rating for Hims & Hers Health Amid Low Margin Concerns and Competitive Pricing
19d ago
HIMS
Closing Bell Movers: nCino down 29% on earnings miss
Premium
The Fly
Closing Bell Movers: nCino down 29% on earnings miss
19d ago
RKT
ASAN
Eli Lilly says company has no affiliation with Hims & Hers
Premium
The Fly
Eli Lilly says company has no affiliation with Hims & Hers
19d ago
LLY
HIMS
‘Don’t Fall for the Hype,’ Says Top Analyst about HIMS’ Decision to Sell Zepbound
PremiumMarket News
‘Don’t Fall for the Hype,’ Says Top Analyst about HIMS’ Decision to Sell Zepbound
19d ago
LLY
HIMS
BofA says Hims & Hers Zepbound sales will be ‘immaterial’
PremiumThe Fly
BofA says Hims & Hers Zepbound sales will be ‘immaterial’
19d ago
CVS
LLY
Hims & Hers adding access to generic liraglutide, branded tirzepatide
PremiumThe Fly
Hims & Hers adding access to generic liraglutide, branded tirzepatide
19d ago
LLY
HIMS
Hims & Hers to sell Zepbound through telehealth platform, Bloomberg reports
PremiumThe Fly
Hims & Hers to sell Zepbound through telehealth platform, Bloomberg reports
20d ago
LLY
HIMS
Eli Lilly threatens Zepbound copycat makers after shortage, Bloomberg reports
PremiumThe FlyEli Lilly threatens Zepbound copycat makers after shortage, Bloomberg reports
20d ago
LLY
NVO
Why Big Brands Are Quietly Returning to X
Premium
Market News
Why Big Brands Are Quietly Returning to X
22d ago
UL
AXP
HP, Autodesk, Hims & Hers, Quantum, Prospect: Insider Moves Revealed!
Premium
Weekend Updates
HP, Autodesk, Hims & Hers, Quantum, Prospect: Insider Moves Revealed!
23d ago
HPQ
ADSK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >